MergerAug 3, 2026, 05:21 PM
BioLife Solutions Updates Employees on Repligen Merger
AI Summary
BioLife Solutions provided an update to its employees regarding the previously announced merger with Repligen Corporation. On August 3, 2026, BioLife management circulated an email containing a video from Repligen's President and CEO, Olivier Loeillot, which offered additional information about Repligen and the merger. The merger, disclosed on July 21, 2026, will result in BioLife becoming a wholly-owned subsidiary of Repligen, pending regulatory and shareholder approvals, with an expected closing in Q4 2026.
Key Highlights
- Merger agreement between BioLife Solutions and Repligen was previously disclosed on July 21, 2026.
- BioLife management circulated an email to employees on August 3, 2026, with a video from Repligen's CEO.
- The video provided additional information about Repligen and the ongoing merger.
- The merger involves BioLife becoming a wholly-owned subsidiary of Repligen through a two-step process.
- The transaction requires regulatory and shareholder approvals.
- The merger is expected to close in the fourth quarter of 2026.
- Until closing, BioLife and Repligen will operate as separate, independent companies.
Price Impact
More from BLFS